Clinical Trial Update: A Study to Evaluate the Relative Bioavailability and Food Effect of a VX-118 Tablet Formulation [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the relative bioavailability and food effect of VX-118 tablet formulation has been completed in cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• VX-118

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED